Brighton Jones LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
21,632
+11,870
+122% +$958K 0.03% 345
2026
Q1
$846K Buy
+9,762
New +$935K 0.02% 521
2025
Q4
Sell
-14,297
Closed -$1.36M 583
2025
Q3
$1.36M Buy
14,297
+6,647
+87% +$611K 0.03% 314
2025
Q2
$667K Sell
7,650
-34,026
-82% -$2.89M 0.02% 443
2025
Q1
$3.75M Buy
41,676
+1,687
+4% +$151K 0.12% 106
2024
Q4
$3.19M Buy
39,989
+37,265
+1,368% +$3.23M 0.09% 113
2024
Q3
$245K Sell
2,724
-7,134
-72% -$600K 0.01% 478
2024
Q2
$776K Sell
9,858
-696
-7% -$57.1K 0.03% 266
2024
Q1
$920K Sell
10,554
-315
-3% -$26.9K 0.03% 234
2023
Q4
$896K Buy
10,869
+197
+2% +$15K 0.04% 223
2023
Q3
$836K Buy
10,672
+626
+6% +$52.4K 0.04% 208
2023
Q2
$885K Buy
10,046
+2,543
+34% +$219K 0.04% 204
2023
Q1
$605K Sell
7,503
-586
-7% -$47.8K 0.03% 249
2022
Q4
$629K Sell
8,089
-1,846
-19% -$150K 0.04% 216
2022
Q3
$802K Buy
9,935
+1,189
+14% +$107K 0.05% 180
2022
Q2
$785K Buy
8,746
+296
+4% +$30K 0.05% 182
2022
Q1
$938K Buy
8,450
+287
+4% +$30.3K 0.04% 183
2021
Q4
$844K Buy
8,163
+355
+5% +$41.1K 0.04% 196
2021
Q3
$979K Buy
7,808
+476
+6% +$61.6K 0.05% 160
2021
Q2
$910K Buy
7,332
+520
+8% +$65.3K 0.05% 168
2021
Q1
$805K Buy
6,812
+2,695
+65% +$316K 0.05% 172
2020
Q4
$482K Sell
4,117
-437
-10% -$48.1K 0.03% 218
2020
Q3
$473K Buy
4,554
+715
+19% +$71.8K 0.03% 197
2020
Q2
$352K Buy
3,839
+356
+10% +$34.1K 0.03% 203
2020
Q1
$314K Buy
3,483
+564
+19% +$60K 0.03% 205
2019
Q4
$331K Buy
2,919
+168
+6% +$18.4K 0.04% 226
2019
Q3
$299K Buy
2,751
+605
+28% +$63.1K 0.03% 232
2019
Q2
$209K Sell
2,146
-1,071
-33% -$97.8K 0.02% 287
2019
Q1
$293K Buy
3,217
+176
+6% +$15.8K 0.04% 229
2018
Q4
$277K Buy
3,041
+498
+20% +$46.5K 0.04% 202
2018
Q3
$250K Hold
2,543
0.03% 230
2018
Q2
$218K Sell
2,543
-169
-6% -$14.1K 0.03% 271
2018
Q1
$218K Sell
2,712
-1,050
-28% -$86.6K 0.03% 267
2017
Q4
$304K Buy
3,762
+676
+22% +$54.1K 0.04% 208
2017
Q3
$240K Buy
3,086
+205
+7% +$17K 0.03% 238
2017
Q2
$256K Buy
+2,881
New +$243K 0.04% 214
2016
Q4
Sell
-6,501
Closed -$562K 168
2016
Q3
$562K Buy
6,501
+483
+8% +$42.1K 0.09% 112
2016
Q2
$522K Sell
6,018
-366
-6% -$29.6K 0.09% 109
2016
Q1
$479K Buy
6,384
+907
+17% +$68.3K 0.09% 113
2015
Q4
$421K Buy
5,477
+141
+3% +$10.6K 0.08% 119
2015
Q3
$357K Buy
+5,336
New +$393K 0.08% 127
2015
Q2
Sell
-5,671
Closed -$442K 192
2015
Q1
$442K Sell
5,671
-1,785
-24% -$135K 0.1% 105
2014
Q4
$538K Sell
7,456
-6,045
-45% -$420K 0.12% 95
2014
Q3
$836K Buy
13,501
+2,984
+28% +$190K 0.19% 65
2014
Q2
$671K Buy
10,517
+228
+2% +$13.8K 0.15% 72
2014
Q1
$633K Sell
10,289
-319
-3% -$18.6K 0.15% 71
2013
Q4
$609K Buy
10,608
+3,933
+59% +$223K 0.14% 80
2013
Q3
$355K Buy
+6,675
New +$359K 0.09% 97

Other funds holding MDT

Brighton Jones LLC's MDT Position: Q2 2026 in Review

Brighton Jones LLC increased its Medtronic (MDT) stake by 122% in Q2 2026, buying an estimated $958K and bringing the position to 21,632 shares worth $1.69M. The position accounts for 0.03% of the portfolio, ranked #345.

Brighton Jones LLC first reported a position in MDT in Q3 2013 and has held it in 48 quarters since. The position peaked at $3.75M in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Brighton Jones LLC held 21,632 shares of Medtronic worth $1.69M as of Q2 2026.
  • Brighton Jones LLC bought 11,870 Medtronic shares in Q2 2026, an estimated $958K.
  • Medtronic made up 0.03% of Brighton Jones LLC's portfolio in Q2 2026, its #345 holding.
  • Brighton Jones LLC first reported a position in Medtronic in Q3 2013 and has held it in 48 quarters since.
  • Brighton Jones LLC's Medtronic position peaked at $3.75M in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.